Loading clinical trials...
Loading clinical trials...
This is a biomedical, single-center, and prospective study of a consecutive patients cohort in acute ischemic stroke with carotid plaque.
The main objective of this study is to evaluate the prevalence of the contrast taking carotid plaques in these acute ischemic strokes. The secondary objectives are: * to determine the clinical, sonographic, CT scanner and MRI characteristics of patients in constituted acute cerebral ischemia with carotid atherosclerotic plaque taking contrast to the doppler ultrasound. * to explore of the plaque contrast enhancement at 6 months (new injection).
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Centre Hospitalier de Versailles
Le Chesnay, France
Start Date
August 1, 2015
Primary Completion Date
August 1, 2017
Completion Date
August 1, 2017
Last Updated
March 15, 2018
35
ACTUAL participants
Contrast injection Sonovue®
OTHER
Lead Sponsor
Versailles Hospital
Collaborators
NCT06757764
NCT07140406
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07121088